News
Bristol Myers and Pfizer said on Thursday they will start selling their blockbuster blood thinner, Eliquis, directly to ...
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...
Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...
Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.
Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...
The joint venture is launching a direct-to-consumer service of Eliquis after discussions with the Trump administration.
Many studies have shown that even though these medicines have risks, these risks are much lower than the risk of a stroke ...
Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly ...
The health sector is witnessing notable developments. Bristol Myers and Pfizer are offering Eliquis at a discounted rate.
The reduced rate will still be almost 10 times the average monthly out-of-pocket costs paid by commercially insured patients.
Pfizer (PFE), in collaboration with Bristol Myers Squibb, has introduced a direct-to-patient option for Eliquis®, potentially ...
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results